SGLT2 Inhibitors Market Size, Trends, & Growth Report, 2030

Global SGLT2 Inhibitors Market Research Report: Forecast (2025-2030)

SGLT2 Inhibitors Market Size - By Drug Type (Jardiance [empagliflozin], Farxiga [dapagliflozin], Invokana [canagliflozin], Inpefa [sotagliflozin], Qtern [dapagliflozin/saxagliptin], Others), By Applic... ... , Others), By Application (Type 2 Diabetes, Cardiovascular, Chronic Kidney Disease [CKD], Others), By End User (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and others Read more

Healthcare
Jul 2025
Pages 190
Report Format: PDF, Excel, PPT

Market Definition

SGLT2 Inhibitors are oral medications that are used to block the action of a protein found inside the kidneys called sodium-glucose co-transporter 2 (SGLT2), which is responsible for reabsorbing glucose from urine into the bloodstream, increasing blood-sugar levels.

Market Insights & Analysis: Global SGLT2 Inhibitors Market (2025-30):

The Global SGLT2 Inhibitors Market size was valued at around USD 18.41 billion in 2024 and is projected to reach USD 30.34 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 8.68% during the forecast period, i.e., 2025-30. The Global SGLT2 Inhibitor Industry is significantly growing due to several growth factors, including the rising burden of chronic disorders like type 2 diabetes, chronic kidney disorders, cardiovascular diseases, etc., the governmental support from different countries for the healthcare development & mass screening for these chronic disorders, the globally rising aging population, and the adoption of the next-generation SGLT2 inhibitors, and many more. One of the most prominent growth factors is the rapidly increasing elderly population globally, which is highly prone to these chronic disorders and highly demands early detection and better treatment solutions, thus increasing the demand for advanced medications such as SGLT2 inhibitors.

Report Coverage	Details
Historical Years	2020–23
Base Years	2024
Forecast Years	2025–30
Market Value in 2024	USD 18.41 Billion
Market Value by 2030	USD 30.34 Billion
CAGR (2025–30)	8.68%
Leading Region	North America
Top Key Players	Astellas, AstraZeneca, Boehringer Ingelheim International, Bristol-Myers Squibb Company, Eli Lilly and Company, Glenmark Pharmaceuticals, Johnson & Johnson (Janssen Pharmaceuticals), Lexicon Pharmaceuticals, Lupin Limited, Merck, Sanofi, TheracosBio, and Others
Segmentation	By Drug Type (Jardiance [empagliflozin], Farxiga [dapagliflozin], Invokana [canagliflozin], Inpefa [sotagliflozin], Qtern [dapagliflozin/saxagliptin], Others), By Application (Type 2 Diabetes, Cardiovascular, Chronic Kidney Disease [CKD], Others), By End User (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and others
Key Report Highlights	Market Dimensions & Projections Pricing Evaluation Recent Strategic Moves by Companies Primary Stakeholders Import/Export Trend Analysis Competitive Landscape Assessment Emerging Opportunities Market Trends and Indicators

*Boost strategic growth with in-depth market analysis - Get a free sample preview today!

Additionally, the governments form different countries, such as India, Indonesia, Canada, China, the US, etc., are actively supporting this market by heavily investing in the mass screening programs for different diseases, including type 2 diabetes. Also, the continuous research and development related to the SGLT2 inhibitor-based treatment for diseases other than type 2 diabetes are creating ample growth opportunities for this market to grow further. This leads to the rapid adoption of the advanced versions of the medicines, including the next-generation SGLT2 Inhibitors with enhanced efficiency and better treatment options over traditional ones.

However, the high upfront cost is a major challenge in this market, as it puts a financial barrier to a large number of the population, including the rural one. In addition, the lack of awareness among individuals, especially in rural and remote areas of the world, is further restraining the market’s growth & expansion.

Global SGLT2 Inhibitors Market Driver:

High Prevalence of Chronic Diseases – The market demand is driven by the high burden of chronic disorders globally, especially cardiovascular diseases, chronic disorders, and type 2 diabetes. For instance, as per the International Diabetes Federation (2021), there were over 540 million adult patients with type 2 diabetes globally, which is further expected to reach more than 640 million. Similarly, chronic kidney disease (CKD) is also highly prevalent globally, accounting for more than 840 million individuals all around the world. Also, more than 65 million individuals experience heart failure globally.

These are increasing the demand for advanced medication such as the SGLT2 Inhibitors, which can inhibit the action of the SGLT2 protein and are highly effective in overcoming these diseases, thus increasing market growth. It has led to the expansion of the SGLT2-inhibitor-based drugs' active pharmaceutical ingredient plants (API) worldwide. For instance, there are about 40-50 API plants globally that are specific to SGLT2 inhibitors.

Market Segmentation
Introduction
1. Product Definition
2. Research Process
3. Assumptions
Executive Summary
Global SGLT2 Inhibitors Market Regulations, Policies & Product Standards
Global SGLT2 Inhibitors Market Trends & Developments
Global SGLT2 Inhibitors Market Dynamics
1. Drivers
2. Challenges
Global SGLT2 Inhibitors Market Hotspots & Opportunities
Global SGLT2 Inhibitors Market Value Chain Analysis
Global SGLT2 Inhibitors Market Outlook, 2020-2030F
1. Market Size & Analysis
  1. Market Revenues (USD Million)
2. Market Share & Analysis
  1. By Drug Type
    1. Jardiance (empagliflozin) - Market Size & Forecast 2020-2030, USD Million
    2. Farxiga (dapagliflozin) - Market Size & Forecast 2020-2030, USD Million
    3. Invokana (canagliflozin) - Market Size & Forecast 2020-2030, USD Million
    4. Inpefa (sotagliflozin) - Market Size & Forecast 2020-2030, USD Million
    5. Qtern (dapagliflozin/saxagliptin) - Market Size & Forecast 2020-2030, USD Million
    6. Others- Market Size & Forecast 2020-2030, USD Million
  2. By Application
    1. Type 2 Diabetes- Market Size & Forecast 2020-2030, USD Million
    2. Cardiovascular- Market Size & Forecast 2020-2030, USD Million
    3. Chronic Kidney Disease (CKD) - Market Size & Forecast 2020-2030, USD Million
    4. Others- Market Size & Forecast 2020-2030, USD Million
  3. By End User
    1. Hospital Pharmacies- Market Size & Forecast 2020-2030, USD Million
    2. Retail Pharmacies- Market Size & Forecast 2020-2030, USD Million
    3. Online Pharmacies- Market Size & Forecast 2020-2030, USD Million
  4. By Region
    1. North America
    2. South America
    3. Europe
    4. The Middle East & Africa
    5. Asia-Pacific
  5. By Company
    1. Revenue Shares
    2. Competition Characteristics
North America SGLT2 Inhibitors Market Outlook, 2020-2030F
1. Market Size & Analysis
  1. Market Revenues (USD Million)
2. Market Share & Analysis
  1. By Drug Type- Market Size & Forecast 2020-2030, USD Million
  2. By Indication - Market Size & Forecast 2020-2030, USD Million
  3. By Frequency Type- Market Size & Forecast 2020-2030, USD Million
  4. By End User- Market Size & Forecast 2020-2030, USD Million
  5. By Country
    1. The US
    2. Canada
    3. Mexico
3. The US SGLT2 Inhibitors Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. Market Revenues (USD Million)
  2. Market Share & Analysis
    1. By Drug Type- Market Size & Forecast 2020-2030, USD Million
    2. By End User- Market Size & Forecast 2020-2030, USD Million
4. Canada SGLT2 Inhibitors Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. Market Revenues (USD Million)
  2. Market Share & Analysis
    1. By Drug Type- Market Size & Forecast 2020-2030, USD Million
    2. By End User- Market Size & Forecast 2020-2030, USD Million
5. Mexico SGLT2 Inhibitors Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. Market Revenues (USD Million)
  2. Market Share & Analysis
    1. By Drug Type- Market Size & Forecast 2020-2030, USD Million
    2. By End User- Market Size & Forecast 2020-2030, USD Million
South America SGLT2 Inhibitors Market Outlook, 2020-2030F
1. Market Size & Analysis
  1. Market Revenues (USD Million)
2. Market Share & Analysis
  1. By Drug Type- Market Size & Forecast 2020-2030, USD Million
  2. By Indication - Market Size & Forecast 2020-2030, USD Million
  3. By Frequency Type- Market Size & Forecast 2020-2030, USD Million
  4. By End User- Market Size & Forecast 2020-2030, USD Million
  5. By Country
    1. Brazil
    2. Argentina
    3. Rest of South America
3. Brazil SGLT2 Inhibitors Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. Market Revenues (USD Million)
  2. Market Share & Analysis
    1. By Drug Type- Market Size & Forecast 2020-2030, USD Million
    2. By End User- Market Size & Forecast 2020-2030, USD Million
4. Argentina SGLT2 Inhibitors Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. Market Revenues (USD Million)
  2. Market Share & Analysis
    1. By Drug Type- Market Size & Forecast 2020-2030, USD Million
    2. By End User- Market Size & Forecast 2020-2030, USD Million
Europe SGLT2 Inhibitors Market Outlook, 2020-2030F
1. Market Size & Analysis
  1. Market Revenues (USD Million)
2. Market Share & Analysis
  1. By Drug Type- Market Size & Forecast 2020-2030, USD Million
  2. By Indication - Market Size & Forecast 2020-2030, USD Million
  3. By Frequency Type- Market Size & Forecast 2020-2030, USD Million
  4. By End User- Market Size & Forecast 2020-2030, USD Million
  5. By Country
    1. Germany
    2. The UK
    3. France
    4. Spain
    5. Italy
    6. Rest of Europe
3. Germany SGLT2 Inhibitors Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. Market Revenues (USD Million)
  2. Market Share & Analysis
    1. By Drug Type- Market Size & Forecast 2020-2030, USD Million
    2. By End User- Market Size & Forecast 2020-2030, USD Million
4. The UK SGLT2 Inhibitors Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. Market Revenues (USD Million)
  2. Market Share & Analysis
    1. By Drug Type- Market Size & Forecast 2020-2030, USD Million
    2. By End User- Market Size & Forecast 2020-2030, USD Million
5. France SGLT2 Inhibitors Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. Market Revenues (USD Million)
  2. Market Share & Analysis
    1. By Drug Type- Market Size & Forecast 2020-2030, USD Million
    2. By End User- Market Size & Forecast 2020-2030, USD Million
6. Spain SGLT2 Inhibitors Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. Market Revenues (USD Million)
  2. Market Share & Analysis
    1. By Drug Type- Market Size & Forecast 2020-2030, USD Million
    2. By End User- Market Size & Forecast 2020-2030, USD Million
7. Italy SGLT2 Inhibitors Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. Market Revenues (USD Million)
  2. Market Share & Analysis
    1. By Drug Type- Market Size & Forecast 2020-2030, USD Million
    2. By End User- Market Size & Forecast 2020-2030, USD Million
The Middle East & Africa SGLT2 Inhibitors Market Outlook, 2020-2030F
1. Market Size & Analysis
  1. Market Revenues (USD Million)
2. Market Share & Analysis
  1. By Drug Type- Market Size & Forecast 2020-2030, USD Million
  2. By Indication - Market Size & Forecast 2020-2030, USD Million
  3. By Frequency Type- Market Size & Forecast 2020-2030, USD Million
  4. By End User- Market Size & Forecast 2020-2030, USD Million
  5. By Country
    1. The UAE
    2. Saudi Arabia
    3. South Africa
    4. Rest of the Middle East & Africa
3. The UAE SGLT2 Inhibitors Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. Market Revenues (USD Million)
  2. Market Share & Analysis
    1. By Drug Type- Market Size & Forecast 2020-2030, USD Million
    2. By End User- Market Size & Forecast 2020-2030, USD Million
4. Saudi Arabia SGLT2 Inhibitors Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. Market Revenues (USD Million)
  2. Market Share & Analysis
    1. By Drug Type- Market Size & Forecast 2020-2030, USD Million
    2. By End User- Market Size & Forecast 2020-2030, USD Million
5. South Africa SGLT2 Inhibitors Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. Market Revenues (USD Million)
  2. Market Share & Analysis
    1. By Drug Type- Market Size & Forecast 2020-2030, USD Million
    2. By End User- Market Size & Forecast 2020-2030, USD Million
Asia-Pacific SGLT2 Inhibitors Market Outlook, 2020-2030F
1. Market Size & Analysis
  1. Market Revenues (USD Million)
2. Market Share & Analysis
  1. By Drug Type- Market Size & Forecast 2020-2030, USD Million
  2. By Indication - Market Size & Forecast 2020-2030, USD Million
  3. By Frequency Type- Market Size & Forecast 2020-2030, USD Million
  4. By End User- Market Size & Forecast 2020-2030, USD Million
  5. By Country
    1. China
    2. India
    3. Japan
    4. South Korea
    5. Australia
    6. Rest of Asia-Pacific
3. China SGLT2 Inhibitors Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. Market Revenues (USD Million)
  2. Market Share & Analysis
    1. By Drug Type- Market Size & Forecast 2020-2030, USD Million
    2. By End User- Market Size & Forecast 2020-2030, USD Million
4. India SGLT2 Inhibitors Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. Market Revenues (USD Million)
  2. Market Share & Analysis
    1. By Drug Type- Market Size & Forecast 2020-2030, USD Million
    2. By End User- Market Size & Forecast 2020-2030, USD Million
5. Japan SGLT2 Inhibitors Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. Market Revenues (USD Million)
  2. Market Share & Analysis
    1. By Drug Type- Market Size & Forecast 2020-2030, USD Million
    2. By End User- Market Size & Forecast 2020-2030, USD Million
6. South Korea SGLT2 Inhibitors Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. Market Revenues (USD Million)
  2. Market Share & Analysis
    1. By Drug Type- Market Size & Forecast 2020-2030, USD Million
    2. By End User- Market Size & Forecast 2020-2030, USD Million
7. Australia SGLT2 Inhibitors Market Outlook, 2020-2030F
  1. Market Size & Analysis
    1. Market Revenues (USD Million)
  2. Market Share & Analysis
    1. By Drug Type- Market Size & Forecast 2020-2030, USD Million
    2. By End User- Market Size & Forecast 2020-2030, USD Million
Global SGLT2 Inhibitors Market Key Strategic Imperatives for Growth & Success
Competitive Outlook
1. Company Profiles
  1. Astellas
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  2. AstraZeneca
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  3. Boehringer Ingelheim International
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  4. Bristol-Myers Squibb Company
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  5. Eli Lilly and Company
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  6. Glenmark Pharmaceuticals
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  7. Johnson & Johnson (Janssen Pharmaceuticals)
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  8. Lexicon Pharmaceuticals
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  9. Lupin Limited
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  10. Merck
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  11. Sanofi
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  12. TheracosBio
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  13. Others
Disclaimer

MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

Full Name*:

Company Name*:

Business Email*:

Country Name*:

Contact Number*:

Message:

Flexible Licensing Options

We offer flexible licensing options to cater to varying organizational needs. Choose the pricing pack that best suits your requirements:

Buy Now

Inquire Before Buying